Home/Filings/4/0001104659-21-112940
4//SEC Filing

Romano Sarah 4

Accession 0001104659-21-112940

CIK 0001372514other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:16 PM ET

Size

5.2 KB

Accession

0001104659-21-112940

Insider Transaction Report

Form 4
Period: 2021-09-02
Romano Sarah
Interim CFO
Transactions
  • Tax Payment

    Common Stock

    2021-09-02$1.81/sh84$15223,225 total
Footnotes (2)
  • [F1]Sale of shares to cover taxes due on restricted stock that vested on 09/01/2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.81, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1
  • filerCIK 0001697536

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:16 PM ET
Size
5.2 KB